Follow
Amanda Fitzpatrick
Amanda Fitzpatrick
Verified email at kcl.ac.uk
Title
Cited by
Cited by
Year
Chemotherapy response score: development and validation of a system to quantify histopathologic response to neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma
S Böhm, A Faruqi, I Said, M Lockley, E Brockbank, A Jeyarajah, ...
Journal of Clinical Oncology 33 (22), 2457-2463, 2015
2512015
Topically applied S‐nitrosothiol‐containing hydrogels as experimental and pharmacological nitric oxide donors in human skin
AB Seabra, A Fitzpatrick, J Paul, MG De Oliveira, R Weller
British journal of dermatology 151 (5), 977-983, 2004
1332004
Neoadjuvant chemotherapy modulates the immune microenvironment in metastases of tubo-ovarian high-grade serous carcinoma
S Böhm, A Montfort, OMT Pearce, J Topping, P Chakravarty, GLA Everitt, ...
Clinical Cancer Research 22 (12), 3025-3036, 2016
1292016
An open label clinical trial of complement inhibition in multifocal motor neuropathy
AM Fitzpatrick, CA Mann, S Barry, K Brennan, JR Overell, HJ Willison
Journal of the Peripheral Nervous System 16 (2), 84-91, 2011
992011
Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy
F Galban‐Horcajo, AM Fitzpatrick, AJ Hutton, SM Dunn, G Kalna, ...
European Journal of Neurology 20 (1), 62-70, 2013
552013
Assessing CSF ctDNA to improve diagnostic accuracy and therapeutic monitoring in breast cancer leptomeningeal metastasis
A Fitzpatrick, M Iravani, A Mills, L Childs, T Alaguthurai, A Clifford, ...
Clinical Cancer Research 28 (6), 1180-1191, 2022
322022
Controversial issues in the neoadjuvant treatment of triple-negative breast cancer
A Fitzpatrick, A Tutt
Therapeutic Advances in Medical Oncology 11, 1758835919882581, 2019
272019
Nitric oxide induces human CLA+ CD25+ Foxp3+ regulatory T cells with skin-homing potential
C Yu, A Fitzpatrick, D Cong, C Yao, J Yoo, A Turnbull, J Schwarze, ...
Journal of Allergy and Clinical Immunology 140 (5), 1441-1444. e6, 2017
272017
Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain
M Kijewska, C Viski, F Turrell, A Fitzpatrick, A van Weverwijk, Q Gao, ...
Breast Cancer Research 21, 1-14, 2019
262019
Atlas of lobular breast cancer models: challenges and strategic directions
G Sflomos, K Schipper, T Koorman, A Fitzpatrick, S Oesterreich, AV Lee, ...
Cancers 13 (21), 5396, 2021
232021
Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer
MAK Rätze, T Koorman, T Sijnesael, B Bassey-Archibong, R van de Ven, ...
Oncogene 41 (21), 2932-2944, 2022
132022
Outcomes in patients≥ 80 years with a diagnosis of a hepatopancreaticobiliary (HPB) malignancy
AR Lewis, C Cipriano, X Wang, R Ward, A Fitzpatrick, ARM Scott, ...
Medical Oncology 36, 1-9, 2019
92019
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—Results from an international, multicenter analysis coordinated by the AGMT Study Group
SP Gampenrieder, V Dezentjé, M Lambertini, A de Nonneville, M Marhold, ...
ESMO open 8 (1), 100747, 2023
72023
Visual improvement in established central retinal vein occlusion with long-standing macular edema following systemic eculizumab treatment.
D Lockington, F Imrie, J Gillen, A Fitzpatrick, H Willison
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 45 (6 …, 2010
72010
Ultraviolet radiation and bradykinin induce erythema in man independently through a nitric oxide-dependent pathway
DA McKay, A Fitzpatrick, A Turnbull, R Weller
JOURNAL OF INVESTIGATIVE DERMATOLOGY 123 (2), 2004
32004
Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype
A Fitzpatrick, M Iravani, A Mills, D Vicente, T Alaguthurai, I Roxanis, ...
Nature Communications 14 (1), 7408, 2023
22023
Eculizumab in the treatment of multifocal motor neuropathy: a single centre pilot study
H Willison, O James, M Cameron, F Amanda, B Sarah
JOURNAL OF NEUROIMMUNOLOGY 228 (1-2), 136-137, 2010
22010
Refining therapy in patients with HER2-positive breast cancer with central nervous system metastasis
MFFV Batista, I Eiriz, A Fitzpatrick, F Le Du, S Braga, D Alpuim Costa
Breast Care 17 (6), 524-532, 2022
12022
Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer
MAK Rätze, T Koorman, T Sijnesael, B Bassey-Archibong, R van de Ven, ...
Oncogene 41 (26), 3507, 2022
12022
A phase Ib study exploring the combination of everolimus and dovitinib in VEGF-refractory clear cell renal cancer.
AM Fitzpatrick, M Greenwood, A Foreshew, J Nixon, A Sahdev, N Sarwar, ...
Journal of Clinical Oncology 32 (4_suppl), 531-531, 2014
12014
The system can't perform the operation now. Try again later.
Articles 1–20